Despite rapid advances in AI, many drug discovery models still struggle to translate computational predictions into clinical ...

In my previous article, I discussed how AI is rapidly transforming the drug discovery process, significantly accelerating timelines and reducing costs. However, while AI's potential in this domain is ...

Generative AI based on Large Language Models (LLMs), the technology behind popular tools like ChatGPT and Google Gemini, is revolutionizing various industries, including the world of drug discovery.

Opinions expressed by Digital Journal contributors are their own. Bringing a new biologic drug from concept to clinic is a complex journey fraught with technical and regulatory hurdles. For ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

Key factors driving this growth include the increasing need to lower drug development costs and timelines, the rising ...

The US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to accelerate ...